Objectives: To analyse the prevalence of resistance to b-lactams and plasmid-mediated quinolone resistance in Enterobacteriaceae in the paediatric hospital of Uruguay.
Introduction
Enterobacteriaceae harbouring extended-spectrum b-lactamases (ESBLs) have been associated with an increase in mortality and healthcare-associated costs.
1 Co-resistance to fluoroquinolones due to the dissemination of plasmid-mediated quinolone resistance (PMQR) associated with the classical (mutation-based) resistance mechanisms is frequent. 2 Although PMQR can be mediated by Qnr proteins (masking of target site), the production of Aac(6 ′ )Ib-cr or QepA and OqxAB efflux pumps, 2 the first two mechanisms are by far the most frequent.
Data on the occurrence of both ESBLs and PMQR in paediatric patients from South America are scarce. So far, the only report on ESBLs from a paediatric population in Uruguay is that on PER-2 in typical enteropathogenic Escherichia coli (EPEC) strains isolated during the years 1991-93. 3 Although PMQR has been reported in an adult population 4, 5 there are still no data concerning the paediatric population.
Materials and methods
A total of 368 enterobacterial isolates were recovered at the microbiology laboratory of Children's Hospital Pereira Rossell (CHPR) between 1 May and 30 November 2009. Approximately 96% of these isolates were recovered from the following sources: urine culture (82.1%); blood samples (7.9%); faeces (3.8%); or surgical wounds (2.4%). Only one clinically relevant specimen per patient per hospitalization event was included. For re-hospitalized patients, data from different isolates were only recorded if they belonged to different species or to different resistance profiles.
Identification to the species level was performed using the VITEK w 2 Compact system (bioMérieux, Marcy l'Étoile, France).
Antibiotic susceptibility tests were performed by a combination of diffusion tests (following CLSI recommendations 6 ) and using the VITEK w 2 Compact system. Additionally, MICs of cefotaxime, amikacin and ciprofloxacin were determined by Etest for those enterobacteria harbouring ESBLs, according to the manufacturer's recommendations. ESBL screening and confirmatory tests were performed by disc diffusion, as suggested by CLSI guidelines, 6 regardless of bacterial genus or species, as previously suggested for areas of high CTX-M enzyme prevalence. 7 Isolates with positive ESBL screening results were further analysed by PCR for the presence of bla CTX-M , bla TEM , bla PER-2 and bla SHV genes using specific primers. 4 Positive samples were re-amplified using Pfu DNA polymerase (Fermentas Life Sciences) and fully sequenced on both strands.
The genes qnrA, qnrB, qnrS and aac(6 ′ )Ib and the cr variant were sought in ESBL-producing isolates by PCR and amplicon sequencing as previously described. 4 We then used the deduced amino acid sequence of every available QnrB protein in public domain databases to construct a phylogenetic tree by the neighbour-joining method with the aid of MEGA4 software. 8 Isolates harbouring qnr alleles were also tested for the presence of insertion sequences such as ISCR1, IS26, IS903 and ISEcp1 according to Eckert et al.
9
All confirmed ESBL-producing isolates were analysed for the presence of class 1 integrons by PCR, using primers I5/I3, 5 ′ CS/3 ′ CS, qacE1F/sul1b and ORFend/F12R. 4 Conjugation assays were carried out using an E. coli J53 Rif R strain as the recipient; transconjugants were selected on MacConkey agar plates supplemented with rifampicin (150 mg/L) and ceftriaxone (1 mg/L). 10 Incompatibility groups of plasmids carrying ESBL and/or qnr or aac(6 ′ )Ib-cr genes were determined by PCR replicon typing according to Carattoli et al.
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Data on patients within the study period were obtained from the hospital's information bureau (Sistema de Informació n Hospitalaria, El Centro Hospitalario Pereira Rossell en cifras 2009). Data on children in the neonatology service were obtained from the birth register of the CHPR.
Results
Two hundred and seventy-one enterobacteria were recovered from 32557 children in the emergency department, 23/4696 from the neonatology unit and 74/7073 from inpatients from different services of the CHPR (such as the paediatrics wards, intensive care unit, orthopaedics, haematology/oncology and the surgery department). A total of 4945/7073 inpatients (69.9%) were admitted from the emergency department.
Twenty enterobacterial isolates (20/368) were characterized as ESBL producers (16 from paediatrics wards, 3 from neonatology and 1 from the emergency department). Two different isolates were obtained from the same child in two different hospitalization events, yielding a CTX-M-2-producing E. coli strain and a CTX-M-8-producing Klebsiella pneumoniae strain.
The proportion of inpatients having at least one infection episode caused by ESBL-producing enterobacteria was 2.26‰ (16/7073) in paediatrics wards, 0.64‰ (3/4696) in the neonatology department and 0.03‰ (1/32 557) in the emergency department. On the other hand the proportion of enterobacteria carrying ESBLs was 21.6% (16/74), 13% (3/23) and 0.37% (1/271) if samples were obtained from paediatrics wards, the neonatology unit and the emergency department, respectively.
ESBL-producing enterobacteria were recovered from 10 urine samples, 7 blood cultures, 1 skin lesion sample, 1 catheter tip sample and 1 synovial fluid sample. ESBL genes are shown in Table 1 .
Thirteen out of 20 ESBL-harbouring isolates also carried the gene aac(6 ′ )Ib coupled to bla CTX-M-2 , bla CTX-M-8 , bla CTX-M-9 , bla CTX-M-15 , bla SHV-2 or bla SHV-5 . Of these, one isolate carried the aac(6 ′ )Ib7 variant in a class 1 integron and displayed an MIC of amikacin as low as 3 mg/L, whereas another harboured the aac(6 ′ )Ib-cr variant along with bla CTX-M-15. Four isolates harboured qnr variants. Two Enterobacter cloacae isolates carried the genes qnrA1-ampR linked to ISCR1, one Citrobacter freundii carried a qnrB8-like variant along with bla CTX-M-2 , and one K. pneumoniae harboured bla CTX-M-8 and a qnrB variant linked to ISEcp1. Regarding this isolate, both determinants were simultaneously transferred by conjugation, and transconjugants (TcKp737) showed an approximate 12-fold increase in ciprofloxacin MIC (0.38 mg/L versus 0.032 mg/L for the rifampicin-resistant E. coli receptor strain).
The partial nucleotide sequence of the qnrB variant (606 bp), obtained with primers qnrBR 4 and tnpAISEcp1, 9 showed 77% similarity with qnrB17, whereas the deduced amino acid sequence showed 87% identity with the corresponding protein, displaying 26 differences with QnrB1, 25 of which have not been described in the http://www.lahey.org/qnrStudies web site.
Class 1 integrons were detected in 14/20 strains, displaying eight distinct genetic arrays (Table 1 ). Such arrays carried 11 different gene cassettes, partially explaining resistance to aminoglycosides [aadA1, aadA2, aadA5, aadB, aac(6 ′ )Ib and aac(6 ′ )Ib 7 ], trimethoprim (dfrA12, dfrA16, dfrA17 and dfrA25) and b-lactams (bla OXA-2 ).
The bla OXA-2 gene was always detected in integrons such as InK13, which codes for resistance to amikacin, oxyiminocephalosporins and tazobactam-like b-lactamase inhibitors. 12 Concerning isolates carrying bla CTX-M-2 , E. coli 954a harboured a complex integron with a different gene array from the one described above [i.e. aadB-aad2 instead of aac(6 ′ )Ib-bla OXA-2 -orfD]; this particular isolate was susceptible to piperacillin/tazobactam (Table 1) .
Conjugation assay and replicon typing results of the 20 ESBLcarrying isolates are shown in Table 1 .
Discussion
The proportion of ESBL-producing enterobacteria in the paediatrics wards of the CHPR during the study period was 2.3 per 1000, which is lower than in other reports on the subject. 13 Interestingly, the diversity of the detected microorganisms (and EBSLs), as well as the elapsed time between putatively related isolates (such as 532/593 or 954a/984), suggests the García-Fulgueiras et al.
occurrence of sporadic episodes instead of nosocomial outbreaks (Table 1) .
Seventy percent of the inpatients admitted to the CHPR came from the emergency department, where the proportion of ESBLproducing enterobacteria is very low. The remaining 30% of inpatients was composed of patients transferred from hospitals throughout our country since the CHPR is the only tertiary referral paediatric hospital in Uruguay. This diversity of geographical zones could, in part, account for the heterogeneity of ESBLs and enterobacterial species. Demonstrating this, strain 954b carrying CTX-M-8 was isolated from a child living in a city bordering Brazil, the only country in South America that has reported the presence of this ESBL. 14 The implementation of permanent infection control policies may account for the absence of intra-nosocomial outbreaks.
Many of the ESBL-producing isolates were also resistant to aminoglycosides and fluoroquinolones. Thirteen isolates showed MICs of amikacin between ≥8 mg/L and ,32 mg/L; aac(6 ′ )Ib was detected in 12/13 isolates (see Table 1 ). The interpretation of these results changes drastically depending on whether CLSI or European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines are used. Thus, whilst according to EUCAST guidelines the 13 isolates would be considered as resistant or intermediate, such microorganisms would be considered as susceptible to amikacin according to CLSI guidelines.
Interpretation of fluoroquinolone susceptibility levels is also troublesome on account of the emergence of PMQR; for example, only one of the qnr-carrying isolates would be interpreted as resistant according to CLSI, whereas according to EUCAST the number of resistant isolates would be two.
Thus, EUCAST guidelines appear to be a more powerful tool than CLSI guidelines for the detection of probable resistance mechanisms. Well-designed clinical trials are still required in order to verify whether the existing differences in the breakpoints defined by both guidelines could affect the outcome of a course of treatment with such antibiotics. For example, we detected in this work the occurrence of qnr variants conferring MICs of ciprofloxacin as low as 0.125 mg/L; hence, even in cases of MIC values as low as these the treating physician should be alerted about possible treatment failures.
Since the paediatric usage of fluoroquinolones in our country is restricted to life-threatening infections, co-selection of PMQR promoted by the administration of oxyiminocephalosporins or aminoglycosides is a likely explanation for the occurrence of these genes in the CHPR. The diversity of the EBSLs detected in this study is in accordance with previous results 4 that suggest the recent dissemination of CTX-M enzymes. Hence, whilst in Uruguay K. pneumoniae isolates carrying bla CTX-M-2 were detected as early as 1996, 12 no CTX-M-9 and/or CTX-M-15-producing enterobacteria were detected until 2006. 4, 5 Nevertheless, CTX-M-2 is still the most frequent CTX-M variant. Its presence in a complex InK13-like integron 12 within a conjugative plasmid (see Table 1 ), along with the fact that these genetic structures have been circulating in diverse hospitals within our country for the past 15 years, could in part account for this predominance.
Apart from these ESBLs, other resistance genes have appeared in our country, such as aac(6 ′ )Ib-cr (associated with bla CTX-M-15 ), qnrA1 (associated with bla CTX-M-9 ) and the new qnrB variant (qnrBKp737) associated with CTX-M-8. Although QnrBKp737 appears to be clustered with the rest of the QnrB Table 1 . ESBLs and PMQR in hospitalized children in Uruguay sub-family, the phylogenetic analysis indicates that it is clearly different from the rest of the previously described QnrB proteins (see Figure 1) . Additionally, this is the first description of a qnrB allele linked to ISEcp1. This insertion sequence has been found next to several antibiotic resistance genes, such as rmtC (which confers resistance to aminoglycosides), and to various b-lactamases, mainly CTX-M-15.
Since the occurrence of ESBL-producing enterobacteria in the CHPR apparently is not associated with outbreaks, the clinical details of patients harbouring such microorganisms should be studied to identify any predisposing factor that may account for infections caused by them. Nevertheless, this work represents a starting point for the development of surveillance programmes aimed at the detection of ESBLs and PMQR. García-Fulgueiras et al.
